Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data

Affiliations

• ¹ Sanofi, Frankfurt, Germany.
• ² Sanofi, Cambridge, MA, USA.
• ³ Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.
• ⁴ Strasbourg University Hospital, Strasbourg, France.
• ⁵ Acura Kliniken Rheinland-Pfalz AG, Bad Kreuznach, Germany.
• ⁶ University Center of Autoimmunity, University Medical Center Mainz, Mainz, Germany.
• ⁷ Rheumatology Division, Hospital Universitario de La Princesa, IIS-IP and EPID-Future Cátedra, Autónoma University of Madrid (UAM), Madrid, Spain.
• ⁸ Kantonsspital St Gallen, St Gallen, Switzerland.
• ⁹ Section of Rheumatology and Translational Research, Division of Infection and Immunity, Arthritis Research UK CREATE Centre and Welsh Arthritis Research Network (WARN), Cardiff University School of Medicine, Tenovus Building, Heath Park Campus, Cardiff, CF14 4XN, UK. choyeh@cardiff.ac.uk.